We hope that you are staying well and taking time for self-care and connection with others as we continue to navigate a time of physical distancing. You can read more about how MAPS-sponsored MDMA-Assisted Therapy trials are responding to COVID-19 here. The MDMA Therapy Training Program has initiated an educational design project to further develop the training pedagogy and competency framework to support the growth and continued quality of the program over the coming years. Additionally, the training program is supporting clinical supervision of active MDMA-assisted psychotherapy studies, as some sessions are still taking place virtually.
For the 6th consecutive year, MAPS Trainers Annie Mithoefer, BSN, and Michael Mithoefer, M.D., are collaborating with the CIIS Certificate in Psychedelic-Assisted Therapies and Research program to deliver training in MDMA-assisted psychotherapy. In response to current public health needs, the Mithoefers are working with CIIS to modify the training retreat into a hybrid online and in-person format.